资讯

Technique to make CAR T-cells in vivo could transform cancer care
Instead of extracting T-cells and engineering them in a lab, researchers have delivered mRNA directly into circulating immune ...
Is Abeona Therapeutics' Zevaskyn Worth $3.1m Per Treatment, Or Will Krystal Biotech Remain ...
Krystal's Vyjuvek innovative gene therapy leads DEB treatment, overshadowing Abeona's Zevaskyn. Check out the comparison ...